Biomarkers of heart failure in pleural fluid

Chest

Volumn 136, Issue 3, 2009, Pages 671-677

  Porcel, José M ^a   Martínez Alonso, Montserrat ^a   Cao, Gonzalo ^a   Bielsa, Silvia ^a   Sopena, Ana ^a   Esquerda, Aureli ^a  

^a HOSPITAL ARNAU DE VILANOVA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CREATININE; INTERLEUKIN 1 RECEPTOR; PLASMA PROTEIN; ST2 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CELL STRESS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DRESSLER SYNDROME; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEMATOTHORAX; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MUSCLE CELL; MYCOBACTERIUM TUBERCULOSIS; PLEURA DISEASE; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

EID: 65649092770     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-0270     Document Type: Article

References (21)

1. Tang WH, Francis GS, Morrow DA, et al. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure. Clin Biochem 2008; 41:210-221 (Pubitemid 351246749)
2. Porcel JM. The use of probrain natriuretic peptide in pleural fluid for the diagnosis of pleural effusions resulting from heart failure. Curr Opin Pulm Med 2005; 11:329-333
3. Porcel JM. Establishing a diagnosis of pleural effusion due to heart failure. Respirology 2007; 12:654-659
4. Braunwald E. Biomarkers in heart failure. N Engl J Med 2008; 358:2148-2159
5. Rehman SU, Mueller T, Januzzi JL Jr. Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure. J Am Coll Cardiol 2008; 52:1458-1465
6. Porcel JM, Chorda J, Cao G, et al. Comparing serum and pleural fluid pro-brain natriuretic peptide (NT-proBNP) levels with pleural-to-serum albumin gradient for the identification of cardiac effusions misclassified by Light's criteria. Respirology 2007; 12:654-659 (Pubitemid 47414870)
7. Kapoor JR, Perazella MA. Diagnostic and therapeutic approach to acute decompensated heart failure. Am J Med 2007; 120:121-127 (Pubitemid 46175783)
8. Light RW. Pleural effusion. N Engl J Med 2002; 346:1971-1977
9. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148:839-843
10. R Development Core Team 2008. R: a language and environment for statistical computing. Available at: http://www.R-project.org. Accessed July 18, 2009
11. Romero-Candeira S, Hernández L, Romero-Brufao S, et al. Is it meaningful to use biochemical parameters to discriminate between transudative and exudative pleural effusions? Chest 2002; 122:1524-1529
12. Porcel JM, Vives M, Cao G, et al. Measurement of pro-brain natriuretic peptide in pleural fluid for the diagnosis of pleural effusions due to heart failure. Am J Med 2004; 116:417-420 (Pubitemid 38299487)
13. Tomcsányi J, Nagy E, Somlói M, et al. NT-brain natriuretic peptide levels in pleural fluid distinguish between pleural transudates and exudates. Eur J Heart Fail 2004; 6:753-756 (Pubitemid 39470230)
14. Gegenhuber A, Mueller T, Dieplinger B, et al. Plasma B-type natriuretic peptide in patients with pleural effusions: preliminary observations. Chest 2005; 128:1003-1009 (Pubitemid 41140539)
15. Kolditz M, Halank M, Schiemanck CS, et al. High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions. Eur Respir J 2006; 28:144-150 (Pubitemid 44914272)
16. Liao H, Na MJ, Dikensoy O, et al. Diagnostic value of pleural fluid N-terminal pro-brain natriuretic peptide levels in patients with cardiovascular diseases. Respirology 2008; 13: 53-57
17. Han CH, Choi JE, Chung JH. Clinical utility of pleural fluid NT-pro brain natriuretic peptide (NT-proBNP) in patients with pleural effusions. Intern Med 2008; 47:1669-1674
18. Seyhan EC, Altin S, Cetinkaya E, et al. The importance of pleural fluid and serum NT-proBNP levels in differentiating pleural effusion due to heart failure from other causes of effusion. Intern Med 2009; 48:287-293
19. Prontera C, Zucchelli GC, Vittorini S, et al. Comparison between analytical performances of polyclonal and monoclonal electrochemiluminescence immunoassays for NT-proBNP. Clin Chim Acta 2009; 400:70-73
20. Rehman SU, Januzzi JL Jr. Natriuretic peptide testing in clinical medicine. Cardiol Rev 2008; 16:240-249
21. Ordonez-Llanos J, Collinson PO, Christenson RH. Aminoterminal pro-B-type natriuretic peptide: analytic considerations. Am J Cardiol 2008; 101:9-15 (Pubitemid 351173928)